TRB3 mediates vascular remodeling by activating the MAPK signaling pathway in hypoxic pulmonary hypertension

Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as ei...

Full description

Saved in:
Bibliographic Details
Published inRespiratory research Vol. 22; no. 1; pp. 312 - 15
Main Authors Cao, Xiaopei, Fang, Xiaoyu, Guo, Mingzhou, Li, Xiaochen, He, Yuanzhou, Xie, Min, Xu, Yongjian, Liu, Xiansheng
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 14.12.2021
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as either a pro-proliferative or pro-apoptotic factor depending on the specific microenvironment. The regulatory mechanisms of TRB3 in hypoxic PH are poorly understood. We performed studies using TRB3-specific silencing and overexpressing lentiviral vectors to investigate the potential roles of TRB3 on hypoxic pulmonary artery smooth muscle cells (PASMCs). Adeno-associated virus type 1(AVV1) vectors encoding short-hairpin RNAs against rat TRB3 were used to assess the role of TRB3 on hypoxic PH. TRB3 protein expression in PH patients was explored in clinical samples by western blot analysis. The results of whole-rat genome oligo microarrays showed that the expression of TRB3 and endoplasmic reticulum stress (ERS)-related genes was upregulated in hypoxic PASMCs. TRB3 protein expression was significantly upregulated by hypoxia and thapsigargin. In addition, 4-PBA and 4μ8C, both inhibitors of ERS, decreased the expression of TRB3. TRB3 knockdown promoted apoptosis and damaged the proliferative and migratory abilities of hypoxic PASMCs as well as inhibited activation of the MAPK signaling pathway. TRB3 overexpression stimulated the proliferation and migration of PASMCs but decreased the apoptosis of PASMCs, which was partly reversed by specific inhibitors of ERK, JNK and p38 MAPK. The Co-IP results revealed that TRB3 directly interacts with ERK, JNK, and p38 MAPK. Knockdown of TRB3 in rat lung tissue reduced the right ventricular systolic pressure and decreased pulmonary medial wall thickness in hypoxic PH model rats. Further, the expression of TRB3 in lung tissues was higher in patients with PH compared with those who have normal pulmonary artery pressure. TRB3 was upregulated in hypoxic PASMCs and was affected by ERS. TRB3 plays a key role in the pathogenesis of hypoxia-induced PH by binding and activating the ERK, JNK, and p38 MAPK pathways. Thus, TRB3 might be a promising target for the treatment of hypoxic PH.
AbstractList Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as either a pro-proliferative or pro-apoptotic factor depending on the specific microenvironment. The regulatory mechanisms of TRB3 in hypoxic PH are poorly understood.BACKGROUNDHypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as either a pro-proliferative or pro-apoptotic factor depending on the specific microenvironment. The regulatory mechanisms of TRB3 in hypoxic PH are poorly understood.We performed studies using TRB3-specific silencing and overexpressing lentiviral vectors to investigate the potential roles of TRB3 on hypoxic pulmonary artery smooth muscle cells (PASMCs). Adeno-associated virus type 1(AVV1) vectors encoding short-hairpin RNAs against rat TRB3 were used to assess the role of TRB3 on hypoxic PH. TRB3 protein expression in PH patients was explored in clinical samples by western blot analysis.METHODSWe performed studies using TRB3-specific silencing and overexpressing lentiviral vectors to investigate the potential roles of TRB3 on hypoxic pulmonary artery smooth muscle cells (PASMCs). Adeno-associated virus type 1(AVV1) vectors encoding short-hairpin RNAs against rat TRB3 were used to assess the role of TRB3 on hypoxic PH. TRB3 protein expression in PH patients was explored in clinical samples by western blot analysis.The results of whole-rat genome oligo microarrays showed that the expression of TRB3 and endoplasmic reticulum stress (ERS)-related genes was upregulated in hypoxic PASMCs. TRB3 protein expression was significantly upregulated by hypoxia and thapsigargin. In addition, 4-PBA and 4μ8C, both inhibitors of ERS, decreased the expression of TRB3. TRB3 knockdown promoted apoptosis and damaged the proliferative and migratory abilities of hypoxic PASMCs as well as inhibited activation of the MAPK signaling pathway. TRB3 overexpression stimulated the proliferation and migration of PASMCs but decreased the apoptosis of PASMCs, which was partly reversed by specific inhibitors of ERK, JNK and p38 MAPK. The Co-IP results revealed that TRB3 directly interacts with ERK, JNK, and p38 MAPK. Knockdown of TRB3 in rat lung tissue reduced the right ventricular systolic pressure and decreased pulmonary medial wall thickness in hypoxic PH model rats. Further, the expression of TRB3 in lung tissues was higher in patients with PH compared with those who have normal pulmonary artery pressure.RESULTSThe results of whole-rat genome oligo microarrays showed that the expression of TRB3 and endoplasmic reticulum stress (ERS)-related genes was upregulated in hypoxic PASMCs. TRB3 protein expression was significantly upregulated by hypoxia and thapsigargin. In addition, 4-PBA and 4μ8C, both inhibitors of ERS, decreased the expression of TRB3. TRB3 knockdown promoted apoptosis and damaged the proliferative and migratory abilities of hypoxic PASMCs as well as inhibited activation of the MAPK signaling pathway. TRB3 overexpression stimulated the proliferation and migration of PASMCs but decreased the apoptosis of PASMCs, which was partly reversed by specific inhibitors of ERK, JNK and p38 MAPK. The Co-IP results revealed that TRB3 directly interacts with ERK, JNK, and p38 MAPK. Knockdown of TRB3 in rat lung tissue reduced the right ventricular systolic pressure and decreased pulmonary medial wall thickness in hypoxic PH model rats. Further, the expression of TRB3 in lung tissues was higher in patients with PH compared with those who have normal pulmonary artery pressure.TRB3 was upregulated in hypoxic PASMCs and was affected by ERS. TRB3 plays a key role in the pathogenesis of hypoxia-induced PH by binding and activating the ERK, JNK, and p38 MAPK pathways. Thus, TRB3 might be a promising target for the treatment of hypoxic PH.CONCLUSIONSTRB3 was upregulated in hypoxic PASMCs and was affected by ERS. TRB3 plays a key role in the pathogenesis of hypoxia-induced PH by binding and activating the ERK, JNK, and p38 MAPK pathways. Thus, TRB3 might be a promising target for the treatment of hypoxic PH.
Abstract Background Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as either a pro-proliferative or pro-apoptotic factor depending on the specific microenvironment. The regulatory mechanisms of TRB3 in hypoxic PH are poorly understood. Methods We performed studies using TRB3-specific silencing and overexpressing lentiviral vectors to investigate the potential roles of TRB3 on hypoxic pulmonary artery smooth muscle cells (PASMCs). Adeno-associated virus type 1(AVV1) vectors encoding short-hairpin RNAs against rat TRB3 were used to assess the role of TRB3 on hypoxic PH. TRB3 protein expression in PH patients was explored in clinical samples by western blot analysis. Results The results of whole-rat genome oligo microarrays showed that the expression of TRB3 and endoplasmic reticulum stress (ERS)-related genes was upregulated in hypoxic PASMCs. TRB3 protein expression was significantly upregulated by hypoxia and thapsigargin. In addition, 4-PBA and 4μ8C, both inhibitors of ERS, decreased the expression of TRB3. TRB3 knockdown promoted apoptosis and damaged the proliferative and migratory abilities of hypoxic PASMCs as well as inhibited activation of the MAPK signaling pathway. TRB3 overexpression stimulated the proliferation and migration of PASMCs but decreased the apoptosis of PASMCs, which was partly reversed by specific inhibitors of ERK, JNK and p38 MAPK. The Co-IP results revealed that TRB3 directly interacts with ERK, JNK, and p38 MAPK. Knockdown of TRB3 in rat lung tissue reduced the right ventricular systolic pressure and decreased pulmonary medial wall thickness in hypoxic PH model rats. Further, the expression of TRB3 in lung tissues was higher in patients with PH compared with those who have normal pulmonary artery pressure. Conclusions TRB3 was upregulated in hypoxic PASMCs and was affected by ERS. TRB3 plays a key role in the pathogenesis of hypoxia-induced PH by binding and activating the ERK, JNK, and p38 MAPK pathways. Thus, TRB3 might be a promising target for the treatment of hypoxic PH.
Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as either a pro-proliferative or pro-apoptotic factor depending on the specific microenvironment. The regulatory mechanisms of TRB3 in hypoxic PH are poorly understood. We performed studies using TRB3-specific silencing and overexpressing lentiviral vectors to investigate the potential roles of TRB3 on hypoxic pulmonary artery smooth muscle cells (PASMCs). Adeno-associated virus type 1(AVV1) vectors encoding short-hairpin RNAs against rat TRB3 were used to assess the role of TRB3 on hypoxic PH. TRB3 protein expression in PH patients was explored in clinical samples by western blot analysis. The results of whole-rat genome oligo microarrays showed that the expression of TRB3 and endoplasmic reticulum stress (ERS)-related genes was upregulated in hypoxic PASMCs. TRB3 protein expression was significantly upregulated by hypoxia and thapsigargin. In addition, 4-PBA and 4μ8C, both inhibitors of ERS, decreased the expression of TRB3. TRB3 knockdown promoted apoptosis and damaged the proliferative and migratory abilities of hypoxic PASMCs as well as inhibited activation of the MAPK signaling pathway. TRB3 overexpression stimulated the proliferation and migration of PASMCs but decreased the apoptosis of PASMCs, which was partly reversed by specific inhibitors of ERK, JNK and p38 MAPK. The Co-IP results revealed that TRB3 directly interacts with ERK, JNK, and p38 MAPK. Knockdown of TRB3 in rat lung tissue reduced the right ventricular systolic pressure and decreased pulmonary medial wall thickness in hypoxic PH model rats. Further, the expression of TRB3 in lung tissues was higher in patients with PH compared with those who have normal pulmonary artery pressure. TRB3 was upregulated in hypoxic PASMCs and was affected by ERS. TRB3 plays a key role in the pathogenesis of hypoxia-induced PH by binding and activating the ERK, JNK, and p38 MAPK pathways. Thus, TRB3 might be a promising target for the treatment of hypoxic PH.
Background Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as either a pro-proliferative or pro-apoptotic factor depending on the specific microenvironment. The regulatory mechanisms of TRB3 in hypoxic PH are poorly understood. Methods We performed studies using TRB3-specific silencing and overexpressing lentiviral vectors to investigate the potential roles of TRB3 on hypoxic pulmonary artery smooth muscle cells (PASMCs). Adeno-associated virus type 1(AVV1) vectors encoding short-hairpin RNAs against rat TRB3 were used to assess the role of TRB3 on hypoxic PH. TRB3 protein expression in PH patients was explored in clinical samples by western blot analysis. Results The results of whole-rat genome oligo microarrays showed that the expression of TRB3 and endoplasmic reticulum stress (ERS)-related genes was upregulated in hypoxic PASMCs. TRB3 protein expression was significantly upregulated by hypoxia and thapsigargin. In addition, 4-PBA and 4μ8C, both inhibitors of ERS, decreased the expression of TRB3. TRB3 knockdown promoted apoptosis and damaged the proliferative and migratory abilities of hypoxic PASMCs as well as inhibited activation of the MAPK signaling pathway. TRB3 overexpression stimulated the proliferation and migration of PASMCs but decreased the apoptosis of PASMCs, which was partly reversed by specific inhibitors of ERK, JNK and p38 MAPK. The Co-IP results revealed that TRB3 directly interacts with ERK, JNK, and p38 MAPK. Knockdown of TRB3 in rat lung tissue reduced the right ventricular systolic pressure and decreased pulmonary medial wall thickness in hypoxic PH model rats. Further, the expression of TRB3 in lung tissues was higher in patients with PH compared with those who have normal pulmonary artery pressure. Conclusions TRB3 was upregulated in hypoxic PASMCs and was affected by ERS. TRB3 plays a key role in the pathogenesis of hypoxia-induced PH by binding and activating the ERK, JNK, and p38 MAPK pathways. Thus, TRB3 might be a promising target for the treatment of hypoxic PH.
Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as either a pro-proliferative or pro-apoptotic factor depending on the specific microenvironment. The regulatory mechanisms of TRB3 in hypoxic PH are poorly understood. We performed studies using TRB3-specific silencing and overexpressing lentiviral vectors to investigate the potential roles of TRB3 on hypoxic pulmonary artery smooth muscle cells (PASMCs). Adeno-associated virus type 1(AVV1) vectors encoding short-hairpin RNAs against rat TRB3 were used to assess the role of TRB3 on hypoxic PH. TRB3 protein expression in PH patients was explored in clinical samples by western blot analysis. The results of whole-rat genome oligo microarrays showed that the expression of TRB3 and endoplasmic reticulum stress (ERS)-related genes was upregulated in hypoxic PASMCs. TRB3 protein expression was significantly upregulated by hypoxia and thapsigargin. In addition, 4-PBA and 4[mu]8C, both inhibitors of ERS, decreased the expression of TRB3. TRB3 knockdown promoted apoptosis and damaged the proliferative and migratory abilities of hypoxic PASMCs as well as inhibited activation of the MAPK signaling pathway. TRB3 overexpression stimulated the proliferation and migration of PASMCs but decreased the apoptosis of PASMCs, which was partly reversed by specific inhibitors of ERK, JNK and p38 MAPK. The Co-IP results revealed that TRB3 directly interacts with ERK, JNK, and p38 MAPK. Knockdown of TRB3 in rat lung tissue reduced the right ventricular systolic pressure and decreased pulmonary medial wall thickness in hypoxic PH model rats. Further, the expression of TRB3 in lung tissues was higher in patients with PH compared with those who have normal pulmonary artery pressure. TRB3 was upregulated in hypoxic PASMCs and was affected by ERS. TRB3 plays a key role in the pathogenesis of hypoxia-induced PH by binding and activating the ERK, JNK, and p38 MAPK pathways. Thus, TRB3 might be a promising target for the treatment of hypoxic PH.
Background Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is unsatisfactory. Tribbles homolog 3 (TRB3), a member of the pseudokinase family, is upregulated in diverse types of cellular stresses and functions as either a pro-proliferative or pro-apoptotic factor depending on the specific microenvironment. The regulatory mechanisms of TRB3 in hypoxic PH are poorly understood. Methods We performed studies using TRB3-specific silencing and overexpressing lentiviral vectors to investigate the potential roles of TRB3 on hypoxic pulmonary artery smooth muscle cells (PASMCs). Adeno-associated virus type 1(AVV1) vectors encoding short-hairpin RNAs against rat TRB3 were used to assess the role of TRB3 on hypoxic PH. TRB3 protein expression in PH patients was explored in clinical samples by western blot analysis. Results The results of whole-rat genome oligo microarrays showed that the expression of TRB3 and endoplasmic reticulum stress (ERS)-related genes was upregulated in hypoxic PASMCs. TRB3 protein expression was significantly upregulated by hypoxia and thapsigargin. In addition, 4-PBA and 4[mu]8C, both inhibitors of ERS, decreased the expression of TRB3. TRB3 knockdown promoted apoptosis and damaged the proliferative and migratory abilities of hypoxic PASMCs as well as inhibited activation of the MAPK signaling pathway. TRB3 overexpression stimulated the proliferation and migration of PASMCs but decreased the apoptosis of PASMCs, which was partly reversed by specific inhibitors of ERK, JNK and p38 MAPK. The Co-IP results revealed that TRB3 directly interacts with ERK, JNK, and p38 MAPK. Knockdown of TRB3 in rat lung tissue reduced the right ventricular systolic pressure and decreased pulmonary medial wall thickness in hypoxic PH model rats. Further, the expression of TRB3 in lung tissues was higher in patients with PH compared with those who have normal pulmonary artery pressure. Conclusions TRB3 was upregulated in hypoxic PASMCs and was affected by ERS. TRB3 plays a key role in the pathogenesis of hypoxia-induced PH by binding and activating the ERK, JNK, and p38 MAPK pathways. Thus, TRB3 might be a promising target for the treatment of hypoxic PH. Keywords: PH, Hypoxia, PASMCs, TRB3, MAPK
ArticleNumber 312
Audience Academic
Author Li, Xiaochen
Xie, Min
Cao, Xiaopei
He, Yuanzhou
Liu, Xiansheng
Fang, Xiaoyu
Guo, Mingzhou
Xu, Yongjian
Author_xml – sequence: 1
  givenname: Xiaopei
  surname: Cao
  fullname: Cao, Xiaopei
– sequence: 2
  givenname: Xiaoyu
  surname: Fang
  fullname: Fang, Xiaoyu
– sequence: 3
  givenname: Mingzhou
  surname: Guo
  fullname: Guo, Mingzhou
– sequence: 4
  givenname: Xiaochen
  surname: Li
  fullname: Li, Xiaochen
– sequence: 5
  givenname: Yuanzhou
  surname: He
  fullname: He, Yuanzhou
– sequence: 6
  givenname: Min
  surname: Xie
  fullname: Xie, Min
– sequence: 7
  givenname: Yongjian
  surname: Xu
  fullname: Xu, Yongjian
– sequence: 8
  givenname: Xiansheng
  surname: Liu
  fullname: Liu, Xiansheng
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34906150$$D View this record in MEDLINE/PubMed
BookMark eNp9Ul1vFCEUnZga-6F_wAcziS--TIUBBubFZG38aKzRmJr4RljmsstmBrbArO6_l9lttdsYQwhwOedc7uWcFkfOOyiK5xidYyya1xHXLcEVqvPELRIVfVScYNqwqm3Jj6N7--PiNMYVQpgLzp4Ux4S2qMEMnRT99be3pBygsypBLDcq6rFXoQww-A566xblfFsqnexGpemUllB-nn39VEa7cGoHWKu0_Km2pXXlcrv2v6wu12M_eKfCdopASOCi9e5p8dioPsKz2_Ws-P7-3fXFx-rqy4fLi9lVpVlDUmVAGEzMXHPaAOsUb2qjEe_UvMMEMNS4qzk0LWHARYsbTKkwjCnDtRCEGnJWXO51O69Wch3skF8ivbJyF_BhIVVIVvcgdcfqRnRECMNpR5kAQjBHpGWt0AZPWm_2WutxntukwaWg-gPRwxtnl3LhN1I0HOX_yQKvbgWCvxkhJjnYqKHvlQM_Rlk3GFGMCBUZ-vIBdOXHkLu8Q-G6bjllf1ELlQuwzvicV0-icjY1hQnGprTn_0Dl0cFgdTaSsTl-QHhxv9A_Fd55JQPEHqCDjzGAkdqmbAo_1W17iZGcbCn3tpTZlnJnS0kztX5AvVP_D-k3M8LkQw
CitedBy_id crossref_primary_10_1016_j_heliyon_2023_e22922
crossref_primary_10_1007_s11010_024_05173_z
crossref_primary_10_1007_s11626_024_00947_7
crossref_primary_10_1016_j_intimp_2023_110599
crossref_primary_10_1186_s12964_025_02159_2
crossref_primary_10_4196_kjpp_2024_28_1_39
crossref_primary_10_1016_j_ejphar_2023_176077
crossref_primary_10_3389_fgene_2022_916281
crossref_primary_10_1016_j_ydbio_2024_01_011
crossref_primary_10_3892_ijmm_2025_5485
crossref_primary_10_1007_s00424_023_02854_4
crossref_primary_10_1016_j_taap_2023_116596
crossref_primary_10_3390_biomedicines11123109
crossref_primary_10_3390_ijms241210206
crossref_primary_10_1089_ten_tea_2023_0362
crossref_primary_10_1111_1440_1681_13843
Cites_doi 10.1152/ajplung.00189.2015
10.1159/000374015
10.1038/sj.onc.1206367
10.1038/nrm3270
10.1038/sj.cr.7290105
10.1242/jcs.082875
10.1038/ncomms8951
10.1038/emboj.2009.370
10.1210/er.2011-1042
10.1007/s00018-008-8255-3
10.7150/ijbs.29737
10.1016/j.yexcr.2007.07.017
10.1038/sj.emboj.7600596
10.1161/CIRCULATIONAHA.112.133413
10.1016/j.cellsig.2006.06.010
10.1128/MCB.00218-07
10.1152/ajplung.00281.2009
10.1016/j.jacc.2009.04.018
10.1016/j.metabol.2014.03.003
10.1172/JCI37948
10.1146/annurev-med-041717-085955
10.1073/pnas.1214014110
10.1161/CIRCULATIONAHA.113.001585
10.2174/1389203718666170406124547
10.1016/j.yexcr.2015.10.013
10.1074/jbc.M407732200
10.1152/ajplung.00012.2004
10.1126/science.1123374
10.1002/jcp.26279
ContentType Journal Article
Copyright 2021. The Author(s).
COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: 2021. The Author(s).
– notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7U7
7U9
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s12931-021-01908-4
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Toxicology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
Toxicology Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Publicly Available Content Database


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1465-993X
EndPage 15
ExternalDocumentID oai_doaj_org_article_cd5268d388f74d458e3317039598cf1f
PMC8670293
A693558553
34906150
10_1186_s12931_021_01908_4
Genre Journal Article
GeographicLocations China
United States--US
Japan
GeographicLocations_xml – name: China
– name: United States--US
– name: Japan
GrantInformation_xml – fundername: national natural science foundation of china
  grantid: No. 81670048
– fundername: national key research and development programs of china
  grantid: No.2016YFC1304500
– fundername: ;
  grantid: No.2016YFC1304500
– fundername: ;
  grantid: No. 81670048
GroupedDBID ---
0R~
29P
2WC
4.4
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PMFND
3V.
7QL
7U7
7U9
7XB
8FK
AZQEC
C1K
DWQXO
H94
K9.
M7N
PKEHL
PQEST
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c563t-fe8f13fbc746e5da762fc07dabd13e1e21d27e6935e789161448f55af7c8834f3
IEDL.DBID M48
ISSN 1465-993X
1465-9921
IngestDate Wed Aug 27 01:32:23 EDT 2025
Thu Aug 21 14:05:18 EDT 2025
Tue Aug 05 10:58:37 EDT 2025
Sat Aug 23 14:58:18 EDT 2025
Tue Jun 17 21:30:37 EDT 2025
Tue Jun 10 20:39:42 EDT 2025
Mon Jul 21 06:08:13 EDT 2025
Tue Jul 01 02:43:23 EDT 2025
Thu Apr 24 22:52:51 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords PH
TRB3
Hypoxia
MAPK
PASMCs
Language English
License 2021. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c563t-fe8f13fbc746e5da762fc07dabd13e1e21d27e6935e789161448f55af7c8834f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/2611229745?pq-origsite=%requestingapplication%
PMID 34906150
PQID 2611229745
PQPubID 42864
PageCount 15
ParticipantIDs doaj_primary_oai_doaj_org_article_cd5268d388f74d458e3317039598cf1f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8670293
proquest_miscellaneous_2610410348
proquest_journals_2611229745
gale_infotracmisc_A693558553
gale_infotracacademiconefile_A693558553
pubmed_primary_34906150
crossref_citationtrail_10_1186_s12931_021_01908_4
crossref_primary_10_1186_s12931_021_01908_4
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-12-14
PublicationDateYYYYMMDD 2021-12-14
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-14
  day: 14
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Respiratory research
PublicationTitleAlternate Respir Res
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References T Tajsic (1908_CR2) 2011; 1
T Ord (1908_CR9) 2017; 18
X Cao (1908_CR5) 2019; 11
M Tang (1908_CR19) 2008; 65
Y Liu (1908_CR30) 2018; 233
B Hong (1908_CR21) 2019; 15
F Hua (1908_CR33) 2011; 124
X Li (1908_CR16) 2016; 310
E Kiss-Toth (1908_CR18) 2004; 279
L Qi (1908_CR28) 2006; 312
D Sun (1908_CR22) 2018; 10
L Hadri (1908_CR23) 2013; 128
D Ord (1908_CR11) 2007; 313
KK Sheares (1908_CR31) 2004; 287
N Fang (1908_CR10) 2014; 63
F Hua (1908_CR24) 2015; 6
L Wei (1908_CR15) 2010; 298
C Hetz (1908_CR4) 2012; 13
M Salazar (1908_CR25) 2009; 119
N Ohoka (1908_CR7) 2005; 24
W Yu (1908_CR29) 2019; 12
MC Chan (1908_CR26) 2007; 27
S Prudente (1908_CR13) 2012; 33
W Zhang (1908_CR17) 2002; 12
Z Hegedus (1908_CR32) 2007; 19
Y He (1908_CR12) 2015; 339
E Spiekerkoetter (1908_CR1) 2018; 70
P Dromparis (1908_CR6) 2013; 127
AJ Bowers (1908_CR8) 2003; 22
J Izrailit (1908_CR20) 2013; 110
NW Morrell (1908_CR3) 2009; 54
MC Chan (1908_CR27) 2010; 29
X Yu (1908_CR14) 2015; 35
References_xml – volume: 310
  start-page: L299
  year: 2016
  ident: 1908_CR16
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00189.2015
– volume: 35
  start-page: 2079
  year: 2015
  ident: 1908_CR14
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000374015
– volume: 22
  start-page: 2823
  year: 2003
  ident: 1908_CR8
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1206367
– volume: 13
  start-page: 89
  year: 2012
  ident: 1908_CR4
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm3270
– volume: 12
  start-page: 9
  year: 2002
  ident: 1908_CR17
  publication-title: Cell Res
  doi: 10.1038/sj.cr.7290105
– volume: 12
  start-page: 3247
  year: 2019
  ident: 1908_CR29
  publication-title: Int J Clin Exp Pathol
– volume: 124
  start-page: 3235
  year: 2011
  ident: 1908_CR33
  publication-title: J Cell Sci
  doi: 10.1242/jcs.082875
– volume: 6
  start-page: 7951
  year: 2015
  ident: 1908_CR24
  publication-title: Nat Commun
  doi: 10.1038/ncomms8951
– volume: 29
  start-page: 559
  year: 2010
  ident: 1908_CR27
  publication-title: EMBO J
  doi: 10.1038/emboj.2009.370
– volume: 33
  start-page: 526
  year: 2012
  ident: 1908_CR13
  publication-title: Endocr Rev
  doi: 10.1210/er.2011-1042
– volume: 65
  start-page: 2924
  year: 2008
  ident: 1908_CR19
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-008-8255-3
– volume: 15
  start-page: 587
  year: 2019
  ident: 1908_CR21
  publication-title: Int J Biol Sci
  doi: 10.7150/ijbs.29737
– volume: 313
  start-page: 3556
  year: 2007
  ident: 1908_CR11
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2007.07.017
– volume: 11
  start-page: 641
  year: 2019
  ident: 1908_CR5
  publication-title: Am J Transl Res
– volume: 24
  start-page: 1243
  year: 2005
  ident: 1908_CR7
  publication-title: EMBO J
  doi: 10.1038/sj.emboj.7600596
– volume: 10
  start-page: 581
  year: 2018
  ident: 1908_CR22
  publication-title: Am J Transl Res
– volume: 127
  start-page: 115
  year: 2013
  ident: 1908_CR6
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.112.133413
– volume: 19
  start-page: 238
  year: 2007
  ident: 1908_CR32
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2006.06.010
– volume: 27
  start-page: 5776
  year: 2007
  ident: 1908_CR26
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.00218-07
– volume: 298
  start-page: L863
  year: 2010
  ident: 1908_CR15
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00281.2009
– volume: 54
  start-page: S20
  year: 2009
  ident: 1908_CR3
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2009.04.018
– volume: 63
  start-page: 822
  year: 2014
  ident: 1908_CR10
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2014.03.003
– volume: 119
  start-page: 1359
  year: 2009
  ident: 1908_CR25
  publication-title: J Clin Invest
  doi: 10.1172/JCI37948
– volume: 70
  start-page: 45
  year: 2018
  ident: 1908_CR1
  publication-title: Annu Rev Med
  doi: 10.1146/annurev-med-041717-085955
– volume: 1
  start-page: 295
  year: 2011
  ident: 1908_CR2
  publication-title: Compr Physiol
– volume: 110
  start-page: 1714
  year: 2013
  ident: 1908_CR20
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1214014110
– volume: 128
  start-page: 512
  year: 2013
  ident: 1908_CR23
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.113.001585
– volume: 18
  start-page: 819
  year: 2017
  ident: 1908_CR9
  publication-title: Curr Protein Pept Sci
  doi: 10.2174/1389203718666170406124547
– volume: 339
  start-page: 122
  year: 2015
  ident: 1908_CR12
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2015.10.013
– volume: 279
  start-page: 42703
  year: 2004
  ident: 1908_CR18
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M407732200
– volume: 287
  start-page: L919
  year: 2004
  ident: 1908_CR31
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00012.2004
– volume: 312
  start-page: 1763
  year: 2006
  ident: 1908_CR28
  publication-title: Science
  doi: 10.1126/science.1123374
– volume: 233
  start-page: 4801
  year: 2018
  ident: 1908_CR30
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.26279
SSID ssj0017875
Score 2.4306283
Snippet Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is...
Background Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment strategies is...
Abstract Background Hypoxic pulmonary hypertension (PH) is a refractory pulmonary vascular remodeling disease, and the efficiency of current PH treatment...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 312
SubjectTerms Animals
Antibodies
Apoptosis
Biotechnology
Blood pressure
Care and treatment
Cell Communication
Cell culture
Cellular stress response
Development and progression
Diagnosis
Disease Models, Animal
Endoplasmic reticulum
Endoplasmic Reticulum Stress - genetics
Flow cytometry
Gene Expression Regulation
Genomes
Health aspects
Health services
Heart
Homology
Hypertension
Hypertension, Pulmonary - etiology
Hypertension, Pulmonary - genetics
Hypertension, Pulmonary - metabolism
Hypoxia
Hypoxia - complications
Hypoxia - genetics
Hypoxia - metabolism
Laboratory animals
Lung diseases
Lungs
Male
MAP kinase
MAP Kinase Signaling System - genetics
MAPK
Microenvironments
Mitogen-activated protein kinases
Muscles
PASMCs
Pathogenesis
Patients
Protein Serine-Threonine Kinases - antagonists & inhibitors
Protein Serine-Threonine Kinases - biosynthesis
Protein Serine-Threonine Kinases - genetics
Proteins
Pulmonary arteries
Pulmonary artery
Pulmonary Artery - pathology
Pulmonary Artery - physiopathology
Pulmonary hypertension
Rats
Rats, Sprague-Dawley
Regulatory mechanisms (biology)
Signal Transduction
Signaling
Smooth muscle
Systolic pressure
Thapsigargin
TRB3
Up-Regulation
Vascular Remodeling - genetics
Ventricle
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9RAEG5kD-JFfBtdpQXBg4RNvzvHWXFZlBGRXdhbk_SDHRgyw-wMOv_eqk4yTBD04jHpCqS7qvqrSqq_IuR9kyrZ8sqUqRKylCzGsraVLCOgSxQRIC7X5sy_6ctr-eVG3Ry1-sKasJ4euF-4Mx-QkCQIa5ORQSobBUBeJWpVW59Ywt0XMG9Mpob_B2CGajwiY_XZHaIapM0cU-e6sqWcwFBm6_9zTz4CpWnB5BECXTwiD4fQkc76V35M7sXuCbk_H36OPyXLqx_nguajIBA_0rHGlG5ibncDGEXbPcWDDPgZFq4g9qPz2fevFIs4miyADYp_Nnu66Ojtfr36tfB0vVuCqTabPd6Jm1zxvuqekeuLz1efLsuhmULplRbbMkWbmEitN1JHFRrYBJOvTGjawERkkbPATdS1UNFYiBkh0bJJqSYZb62QSTwnJ92qiy8JbSCkUKDMhgcmE3YN1Tpxo1WA4IKnUBA2rq3zA9M4NrxYupxxWO16fTjQh8v6cLIgHw_PrHuejb9Kn6PKDpLIkZ1vgOW4wXLcvyynIB9Q4Q49GV7PN8OBBJgkcmK5mc7c80qJgpxOJMED_XR4NBk37AB3DjJTxjlka6og7w7D-CRWtXVxtcsylWTgJLYgL3oLO0xJyDqT9RfETGxvMufpSLe4zfzgVpsKVuzV_1ik1-QBR7dhvGTylJxsN7v4BsKwbfs2e9xvnoYsaQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bi9QwFA66gvgi3re6SgTBBwnb3NMnmRWXRRkR2YV5C500cQeGdpwLOv_eczKdcYuwj21Oocm5fUnOhZB3dSrVVJSWpVIqpniMrHKlYhG8S5QRXFyOzRl_MxdX6stET_oDt1UfVrm3idlQN13AM_JTQPpcCEC_-uPiF8OuUXi72rfQuEvuYekyDOmyk8OGi4Mw6l12kWZVJfg-acaZ0xX6OdhIC9xMV6VjauCYcv3-_630DTc1DKG84ZPOH5GHPZikox33H5M7sX1C7o_76_KnZH7540zSnBwCiJLuo07pMuYGOOC16HRLMbUBD2bhCdAgHY--f6UY1lFnAmxZ_Lve0llLr7eL7s8s0MVmDqtRL7f4Ji5zDHzXPiNX558vP12wvr0CC9rINUvRJS7TNFhlom5qMIsplLappw2XkUfBG2GjqaSO1gGKhK2XS1rXyQbnpEryOTlquzYeE1oDyNDA3lo0XCXsI2pMEtboBuCGSE1B-H5tfehrj2MLjLnPexBn_I4fHvjhMz-8KsiHwzeLXeWNW6nPkGUHSqyanV90y5--V0IfGixu00jnklWN0i5KgE-lrHTlQuKpIO-R4R51G34v1H2KAkwSq2T5kcnV6LWWBTkZUIJOhuHwXmR8bxNW_p8EF-TtYRi_xDi3NnabTFMqDmrjCvJiJ2GHKUlV5fL9BbED2RvMeTjSzq5zxXBnbAkr9vL233pFHghUCC4YVyfkaL3cxNcAudbTN1mv_gKl1yaX
  priority: 102
  providerName: ProQuest
Title TRB3 mediates vascular remodeling by activating the MAPK signaling pathway in hypoxic pulmonary hypertension
URI https://www.ncbi.nlm.nih.gov/pubmed/34906150
https://www.proquest.com/docview/2611229745
https://www.proquest.com/docview/2610410348
https://pubmed.ncbi.nlm.nih.gov/PMC8670293
https://doaj.org/article/cd5268d388f74d458e3317039598cf1f
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED_6AWMvY9_z1gUNBnsY3qwvS34YIxktJSOldA3kTTi21AaCk7kJa_77nRQ7q1kZ7MnYOhtLd-e7k-9-B_A-d4mYskTFLuEiFtTaONOJiC1aF8stmriQmzM6S0_HYjiRkz1o2x01C3hzb2jn-0mN6_mn25-br6jwX4LC6_TzjbdZGBQzHxhniY7FPhyiZVJeUUfiz18FFE65rTaSMdrlSVtEc-8zOoYq4Pn__dW-Y7a6KZV3bNTJY3jUOJekv5WGJ7Bnq6fwYNT8Pn8G88uLASehWAQ9TNJmoZLahoY4aMXIdEN8qYPfqMUz9A7JqH_-nfg0jzwQ-BbGv_INmVXkerNc3M4KslzPUZjzeuOv2DrkxC-q5zA-Ob78dho37RbiQqZ8FTurHeVuWiiRWlnm-Jl0RaLKfFpSbqlltGTKphmXVmn0KjEU007K3KlCay4cfwEH1aKyr4Dk6HRIZHfOSiqc7yuapo6pVJbofjBXRkDbtTVFg0XuW2LMTYhJdGq2_DDIDxP4YUQEH3f3LLdIHP-kHniW7Sg9ina4sKivTKOUpig92E3JtXZKlEJqy9GdSngmM1046iL44BluvPTh6xV5U7KAk_SoWaafBnR6KXkERx1K1NGiO9yKjGlF3GDsShnDeE5G8G437O_0eW-VXawDTSIoqpGO4OVWwnZT4iILcP4RqI7sdebcHalm1wFBXKcqwRV7_V9L-gYeMq8flMVUHMHBql7bt-iRraY92FcT1YPDfn_4Y4jHwfHZ-UUv7G_0ggr-BnIsMrE
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD4anQS8IO4EBhgJxAOKFt8S5wGhFjZ1dK2maZP2ZtLEZpWqpPSi0T_Fb-TYTcoipL3tMbETxT6378TnAvA-s5EYsygJbcRFKKgxYaoiERq0LoYbNHE-Nmc4ivvn4vuFvNiBP00ujAurbHSiV9RFlbt_5PuI9CljiH7ll9mv0HWNcqerTQuNDVsMzPoKXbbF56NvSN8PjB0enH3th3VXgTCXMV-G1ihLuR3niYiNLDLUBjaPkiIbF5QbahgtWGLilEuTKARP6HEoK2Vmk1wpLizH996BXcHRlenAbu9gdHK6PbdA9pebfCYZpimjTZqOivcXzrKi686c-55GKhQtU-g7BvxvF64ZxnbQ5jUrePgQHtTwlXQ3_PYIdkz5GO4O6wP6JzA9O-1x4tNREMOSJs6VzI1vuYN2kozXxCVTuF_BeIX4kwy7JwPiAkkyP8E1Sb7K1mRSksv1rPo9yclsNcX9z-Zrd8fMfdR9VT6F81vZ-mfQKavSvACSIayRyFAZK6iwrnNpHFuWxLJAgMNsEQBt9lbndbVz13Rjqr3Xo2K9oYdGemhPDy0C-LR9Zrap9XHj7J4j2Xamq9Ptb1Tzn7oWe50XrpxOwZWyiSiEVIYjYIt4KlOVW2oD-OgIrp02wc_LszopAhfp6nLpbuzr30vJA9hrzUQtkLeHG5bRtRZa6H8yE8C77bB70kXWlaZa-TmRoCioKoDnGw7bLomL1DcMCCBp8V5rze2RcnLpa5SrOIlwx17e_Flv4V7_bHisj49Gg1dwnznhoCykYg86y_nKvEbAtxy_qaWMwI_bFuy_7pxlNg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TRB3+mediates+vascular+remodeling+by+activating+the+MAPK+signaling+pathway+in+hypoxic+pulmonary+hypertension&rft.jtitle=Respiratory+research&rft.au=Cao%2C+Xiaopei&rft.au=Fang%2C+Xiaoyu&rft.au=Guo%2C+Mingzhou&rft.au=Li%2C+Xiaochen&rft.date=2021-12-14&rft.issn=1465-993X&rft.eissn=1465-993X&rft.volume=22&rft.issue=1&rft_id=info:doi/10.1186%2Fs12931-021-01908-4&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12931_021_01908_4
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-993X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-993X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-993X&client=summon